CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
Joanna Motyka,1 Ewa Gacuta,2 Aleksandra Kicman,3 Monika Kulesza,1 Paweł Malinowski,4 Sławomir Ławicki1 1Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland; 2Department of Perinatology, University Cl...
Main Authors: | Motyka J, Gacuta E, Kicman A, Kulesza M, Malinowski P, Ławicki S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/cxcl12-and-cxcr4-as-potential-early-biomarkers-for-luminal-a-and-lumin-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
by: Joanna Motyka, et al.
Published: (2022-11-01) -
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
by: Hara Takahiko, et al.
Published: (2014-05-01) -
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
by: Heinrich Eileen L, et al.
Published: (2012-04-01) -
CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
by: Seong-Kyu Kim, et al.
Published: (2023-02-01) -
Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)